astragaloside a has been researched along with Cerebral Ischemia in 21 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (9.52) | 29.6817 |
| 2010's | 11 (52.38) | 24.3611 |
| 2020's | 8 (38.10) | 2.80 |
| Authors | Studies |
|---|---|
| Deng, CQ; Ding, H; Huang, XP; Liu, XD; Tang, S; Yang, XQ; Zeng, XB; Zhu, QY | 1 |
| Han, X; Shu, Z; Tang, J; Wang, Y; Yu, L | 1 |
| He, Y; Huang, B; Huang, J; Meng, Y; Shen, F; Wang, L | 1 |
| Liu, C; Tang, B; Wang, L | 1 |
| Ding, Z; He, Y; Lin, B; Wan, H; Wei, X; Yang, J; Yin, J; Zhou, H | 1 |
| Deng, CQ; Ding, H; Huang, MT; Huang, XP; Li, Y; Li, YL; Liu, CX; Liu, XD; Tang, S; Xiong, HL; Zhang, W | 1 |
| Chen, J; Chen, L; Han, Y; Hu, X; Miao, H; Ou, Z; Wang, Y; Yao, J | 1 |
| Huang, H; Liu, W; Xu, Z | 1 |
| Chu, H; Dong, J; Dong, Q; Gao, Z; Huang, C; Tang, Y | 1 |
| Cai, SQ; Wang, D; Xu, F; Ye, J; Zhang, WW | 1 |
| Alves, RD; Cavalcante, JS; Cavalcanti, JRLP; Costa, IM; Fernandes, LCB; Filho, IA; Freire, MAM; Guzen, FP; Lima, FOV; Lucena, EES; Neta, FI; Norrara, B; Queiroz, DB; Rego, ACM | 1 |
| Deng, CQ; Tang, B; Tang, WJ; Tang, YH | 1 |
| Guo, Y; Liu, G; Song, J; Wang, T; Zhou, Z | 1 |
| Cao, YL; Chen, CF; Cheng, HX; Feng, YB; Wang, AW; Xin, W; Zhang, WW | 1 |
| Deng, BX; Deng, CQ; Ding, H; Huang, XP; Lu, JD; Tang, YH | 1 |
| Wang, HL; Xu, MB; Zheng, GQ; Zhou, QH; Zhou, XL | 1 |
| Gao, GD; Gao, L; Li, M; Liu, JP; Qu, YZ; Wei, XY; Zhao, YL; Zhao, ZW | 1 |
| Gong, HL; Li, WP; Li, WZ; Wu, GC; Yin, YY; Zhu, FF | 1 |
| Li, JH; Wan, HT; Zhu, ZH | 1 |
| Gao, GD; Gao, L; Li, M; Liu, YY; Qu, YZ; Wei, XY; Wu, SX; Zhao, ZW | 1 |
| Chen, J; Ding, D; Fu, JH; Hong, Z; Luo, Y; Qin, Z; Zhang, WD; Zhang, X | 1 |
2 review(s) available for astragaloside a and Cerebral Ischemia
| Article | Year |
|---|---|
Astragaloside IV Supplementation Promotes A Neuroprotective Effect in Experimental Models of Neurological Disorders: A Systematic Review.
Topics: Alzheimer Disease; Animals; Brain Ischemia; Encephalomyelitis; Humans; Nervous System Diseases; Neuroprotective Agents; Parkinson Disease; Saponins; Triterpenes | 2019 |
Astragaloside IV for Experimental Focal Cerebral Ischemia: Preclinical Evidence and Possible Mechanisms.
Topics: Amino Acid Sequence; Animals; Brain Ischemia; Drug Evaluation, Preclinical; Models, Molecular; Publication Bias; Saponins; Stroke; Treatment Outcome; Triterpenes | 2017 |
19 other study(ies) available for astragaloside a and Cerebral Ischemia
| Article | Year |
|---|---|
Borneol enhances the protective effect against cerebral ischemia/reperfusion injury by promoting the access of astragaloside IV and the components of Panax notoginseng saponins into the brain.
Topics: Animals; Brain; Brain Ischemia; Camphanes; Panax notoginseng; Rats; Reperfusion Injury; Saponins; Triterpenes | 2022 |
Astragaloside IV ameliorates cerebral ischemia-reperfusion injury via upregulation of PKA and Cx36.
Topics: Animals; bcl-2-Associated X Protein; Brain Ischemia; Cerebral Infarction; Isoquinolines; Proto-Oncogene Proteins c-bcl-2; Rats; Rats, Sprague-Dawley; Reperfusion Injury; Saponins; Sulfonamides; Triterpenes; Up-Regulation | 2022 |
Antihypertension effect of astragaloside IV during cerebral ischemia reperfusion in rats.
Topics: Animals; Brain Ischemia; Disease Models, Animal; Infarction, Middle Cerebral Artery; Rats; Rats, Sprague-Dawley; Reperfusion; Reperfusion Injury; Saponins; Triterpenes | 2023 |
Astragaloside IV mitigates cerebral ischaemia-reperfusion injury via inhibition of P62/Keap1/Nrf2 pathway-mediated ferroptosis.
Topics: Animals; Brain Ischemia; Ferroptosis; Humans; Kelch-Like ECH-Associated Protein 1; Neuroblastoma; NF-E2-Related Factor 2; Oxygen; Rats; Rats, Sprague-Dawley; Reperfusion Injury; Signal Transduction; Stroke | 2023 |
Integrated transcriptomics, proteomics and metabolomics to identify biomarkers of astragaloside IV against cerebral ischemic injury in rats.
Topics: Animals; Biomarkers; Brain Injuries; Brain Ischemia; Drugs, Chinese Herbal; Infarction, Middle Cerebral Artery; Metabolomics; Proteomics; Rats; Rats, Sprague-Dawley; Transcriptome | 2023 |
Effects of borneol combined with astragaloside IV and Panax notoginseng saponins regulation of microglia polarization to promote neurogenesis after cerebral ischaemia.
Topics: Animals; Brain Ischemia; Microglia; Myeloid Differentiation Factor 88; Neurogenesis; NF-kappa B; Panax notoginseng; Rats; Reperfusion Injury; Saponins; Toll-Like Receptor 4 | 2023 |
Astragaloside IV promotes angiogenesis by targeting SIRT7/VEGFA signaling pathway to improve brain injury after cerebral infarction in rats.
Topics: Animals; Brain Injuries; Brain Ischemia; Infarction, Middle Cerebral Artery; Molecular Docking Simulation; Oxygen; Rats; Rats, Sprague-Dawley; Reperfusion Injury; Signal Transduction; Sirtuins | 2023 |
Astragaloside IV Alleviates Cerebral Ischemia-Reperfusion Injury by Activating the Janus Kinase 2 and Signal Transducer and Activator of Transcription 3 Signaling Pathway.
Topics: Animals; Apoptosis; Brain Ischemia; Disease Models, Animal; Janus Kinase 2; Male; Neuroprotective Agents; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Reperfusion Injury; Saponins; Signal Transduction; STAT3 Transcription Factor; Superoxide Dismutase; Triterpenes | 2020 |
Reduction of Ischemic Brain Edema by Combined use of Paeoniflorin and Astragaloside IV via Down-Regulating Connexin 43.
Topics: Animals; Aquaporin 4; Brain Edema; Brain Ischemia; Connexin 43; Down-Regulation; Drug Synergism; Extracellular Signal-Regulated MAP Kinases; Glucosides; JNK Mitogen-Activated Protein Kinases; Male; Monoterpenes; Rats, Sprague-Dawley; Saponins; Signal Transduction; Triterpenes | 2017 |
Buyang Huanwu Decoction ameliorates ischemic stroke by modulating multiple targets with multiple components: In vitro evidences.
Topics: Animals; Apoptosis; Brain Ischemia; Drugs, Chinese Herbal; Glucosides; Isoflavones; Male; Mice; Mice, Inbred BALB C; Monoterpenes; PC12 Cells; Rats; Rats, Sprague-Dawley; RAW 264.7 Cells; Saponins; Stroke; Triterpenes | 2018 |
[Astragaloside IV attenuates cerebral ischemia and reperfusion injury and reduces activation of NLRP3 inflammasome and NF-κB phosphorylation in rats following a transient middle cerebral artery occlusion].
Topics: Animals; Brain Ischemia; Infarction, Middle Cerebral Artery; Inflammasomes; NF-kappa B; NLR Family, Pyrin Domain-Containing 3 Protein; Phosphorylation; Rats; Rats, Sprague-Dawley; Reperfusion Injury; Saponins; Triterpenes | 2019 |
Astragalus injection protects cerebral ischemic injury by inhibiting neuronal apoptosis and the expression of JNK3 after cerebral ischemia reperfusion in rats.
Topics: Animals; Apoptosis; Brain Ischemia; Disease Models, Animal; Down-Regulation; Drugs, Chinese Herbal; Male; Mitogen-Activated Protein Kinase 10; Neurons; Neuroprotective Agents; Rats; Rats, Wistar; Reperfusion Injury; Saponins; Triterpenes | 2013 |
Changes of peripheral-type benzodiazepine receptors in the penumbra area after cerebral ischemia-reperfusion injury and effects of astragaloside IV on rats.
Topics: Animals; Brain; Brain Ischemia; Female; Isoquinolines; Male; Mitochondria; Rats, Sprague-Dawley; Receptors, GABA-A; Reperfusion Injury; Saponins; Triterpenes; Tritium | 2015 |
Effects of the Combination of the Main Active Components of Astragalus and Panax notoginseng on Inflammation and Apoptosis of Nerve Cell after Cerebral Ischemia-Reperfusion.
Topics: Animals; Apoptosis; Astragalus Plant; Brain Ischemia; CA1 Region, Hippocampal; Cell Survival; Disease Models, Animal; Drug Combinations; Endoplasmic Reticulum Chaperone BiP; Ginsenosides; Inflammation; Janus Kinase 1; Male; Mice, Inbred C57BL; Neurons; Neuroprotective Agents; NF-kappa B; Panax notoginseng; Phytotherapy; Reperfusion Injury; Saponins; STAT1 Transcription Factor; Triterpenes | 2015 |
Astragaloside IV attenuates cerebral ischemia-reperfusion-induced increase in permeability of the blood-brain barrier in rats.
Topics: Animals; Blood-Brain Barrier; Brain Ischemia; Male; Membrane Proteins; Microscopy, Electron; Occludin; Permeability; Phosphoproteins; Rats; Rats, Sprague-Dawley; Reperfusion Injury; Saponins; Tight Junctions; Triterpenes; Zonula Occludens-1 Protein | 2009 |
Protective effect of astragaloside on focal cerebral ischemia/reperfusion injury in rats.
Topics: Animals; Brain; Brain Ischemia; Cerebral Infarction; Drugs, Chinese Herbal; Infarction, Middle Cerebral Artery; L-Lactate Dehydrogenase; Lactates; Male; Malondialdehyde; Nerve Growth Factor; Neuroprotective Agents; Nitric Oxide; Nitric Oxide Synthase Type II; Rats; Rats, Sprague-Dawley; Receptor, trkA; Reperfusion Injury; Reverse Transcriptase Polymerase Chain Reaction; Saponins; Superoxide Dismutase; Time Factors; Triterpenes; Water | 2010 |
Chuanxiongzine-astragaloside IV decreases IL-1β and Caspase-3 gene expressions in rat brain damaged by cerebral ischemia/reperfusion: a study of real-time quantitative PCR assay.
Topics: Animals; Brain; Brain Ischemia; Caspase 3; Interleukin-1beta; Male; Neuroprotective Agents; Pyrazines; Random Allocation; Rats; Rats, Sprague-Dawley; Real-Time Polymerase Chain Reaction; Reperfusion Injury; RNA, Messenger; Saponins; Triterpenes | 2011 |
Astragaloside IV protects against focal cerebral ischemia/reperfusion injury correlating to suppression of neutrophils adhesion-related molecules.
Topics: Animals; Blotting, Western; Brain Ischemia; Cell Adhesion; Cell Adhesion Molecules; Enzyme-Linked Immunosorbent Assay; Flow Cytometry; Immunohistochemistry; Interleukin-1beta; Male; Neutrophils; NF-kappa B; Rats; Rats, Sprague-Dawley; Reperfusion Injury; Saponins; Triterpenes; Tumor Necrosis Factor-alpha | 2012 |
Astragaloside IV protects against ischemic brain injury in a murine model of transient focal ischemia.
Topics: Animals; Brain Chemistry; Brain Ischemia; Cardiotonic Agents; Catalase; Cerebral Infarction; Disease Models, Animal; Dose-Response Relationship, Drug; Drugs, Chinese Herbal; Glutathione Peroxidase; Infarction, Middle Cerebral Artery; Lipid Peroxidation; Male; Malondialdehyde; Mice; Mice, Inbred C57BL; Reperfusion Injury; Saponins; Superoxide Dismutase; Triterpenes | 2004 |